A new drug has been found to show promise in targeting the mutations of acute myeloid leukemia (AML), finds a new study at the Perelman School of Medicine at the University of Pennsylvania and Penn''s Abramson Cancer Center.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer